BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33124568)

  • 1. Cryoglobulins: putative effectors of adaptive immune response.
    Basile U; Napodano C; Marino M; Gulli F; Colantuono S; Casato M; Pocino K; Basile V; Todi L; Rapaccini GL; Visentini M
    Clin Exp Rheumatol; 2021; 39 Suppl 129(2):171-179. PubMed ID: 33124568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II mixed cryoglobulinaemia, hepatitis C virus infection, and glomerulonephritis.
    Fornasieri A; D'Amico G
    Nephrol Dial Transplant; 1996; 11 Suppl 4():25-30. PubMed ID: 8918748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection and cryoglobulinaemia.
    Lunel F; Musset L
    Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment.
    Schott P; Hartmann H; Ramadori G
    Histol Histopathol; 2001 Oct; 16(4):1275-85. PubMed ID: 11642746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection.
    Sasso EH
    Ann Med Interne (Paris); 2000 Feb; 151(1):30-40. PubMed ID: 10761560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
    Ghinoi A; Mascia MT; Puccini R; Ferri C
    G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.
    Agnello V
    Springer Semin Immunopathol; 1997; 19(1):111-29. PubMed ID: 9266635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins.
    Napodano C; Gulli F; Rapaccini GL; Marino M; Basile U
    Adv Clin Chem; 2021; 104():299-340. PubMed ID: 34462057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC.
    Cacoub P; Hausfater P; Musset L; Piette JC
    Ann Med Interne (Paris); 2000 Feb; 151(1):20-9. PubMed ID: 10761559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoglobulinemia.
    Tedeschi A; Baratè C; Minola E; Morra E
    Blood Rev; 2007 Jul; 21(4):183-200. PubMed ID: 17289231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cryoglobulins: an overview.
    Dammacco F; Sansonno D; Piccoli C; Tucci FA; Racanelli V
    Eur J Clin Invest; 2001 Jul; 31(7):628-38. PubMed ID: 11454019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed cryoglobulinemia as a model of systemic vasculitis.
    Dammacco F; Sansonno D
    Clin Rev Allergy Immunol; 1997; 15(1):97-119. PubMed ID: 9209804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
    Terrier B; Nagata S; Ise T; Rosenzwajg M; Pastan I; Klatzmann D; Saadoun D; Cacoub P
    Arthritis Rheumatol; 2014 Feb; 66(2):433-43. PubMed ID: 24504816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryoglobulinaemia.
    Roccatello D; Saadoun D; Ramos-Casals M; Tzioufas AG; Fervenza FC; Cacoub P; Zignego AL; Ferri C
    Nat Rev Dis Primers; 2018 Aug; 4(1):11. PubMed ID: 30072738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
    Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
    Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus.
    Fabris P; Tositti G; Giordani MT; Romanò L; Betterle C; Pignattari E; Tagliaferri C; Muratori P; Manfrin V; de Lalla F
    J Med Virol; 2003 Mar; 69(3):339-43. PubMed ID: 12526043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection.
    Wong VS; Egner W; Elsey T; Brown D; Alexander GJ
    Clin Exp Immunol; 1996 Apr; 104(1):25-31. PubMed ID: 8603528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders.
    Gulli F; Basile U; Gragnani L; Fognani E; Napodano C; Colacicco L; Miele L; De Matthaeis N; Cattani P; Zignego AL; Rapaccini GL
    Dig Liver Dis; 2016 Aug; 48(8):927-33. PubMed ID: 27289333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed cryoglobulinemia: new concepts.
    Ramos-Casals M; Trejo O; García-Carrasco M; Cervera R; Font J
    Lupus; 2000; 9(2):83-91. PubMed ID: 10787003
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.